Lobbying

Soter Bio's latest lobbying report covers Q3 2026, at under $5,000. Its first report covers Q4 2025; the issues it reports most are Budget/Appropriations and Defense.

Soter Bio

Latest quarter
$0
Q3 2026 · 1 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2025
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Soter Bio lobbying by quarter
Soter Bio lobbying by quarter
QuarterAmountReports
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$01

By issue

  • Budget and appropriations$0 · 3 reports
  • Defense$0 · 3 reports
  • Disaster planning and emergencies$0 · 3 reports
  • Health issues$0 · 3 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Defense, Dept of (DOD)3 reports
  • Health & Human Services, Dept of (HHS)3 reports
  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports

Firms it paid

Firm
Tenagrity Solutions$04 quarters

Former officials lobbying for it

Former position
JENNY CAROLINE DEBERRYSenior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election CommissionQ3 2026

Lobbying reports

Filed by
07/24for Q3Tenagrity SolutionsUnder $5,000
07/20for Q2Tenagrity SolutionsUnder $5,000
04/20for Q1Tenagrity SolutionsUnder $5,000
02/11for Q4 2025Tenagrity SolutionsUnder $5,000
01/28for Q4 2025Tenagrity SolutionsUnder $5,000